Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Disseminated erythematous papules and nodules.

Haiduk J, Linde J, Vucinic V, Dumann K, Pönitzsch I, Ziemer M.

J Dtsch Dermatol Ges. 2018 Jul 4. doi: 10.1111/ddg.13591. [Epub ahead of print] No abstract available.

PMID:
29972625
2.

Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.

Bill M, Grimm J, Jentzsch M, Kloss L, Goldmann K, Schulz J, Beinicke S, Häntschel J, Cross M, Vucinic V, Pönisch W, Behre G, Franke GN, Lange T, Niederwieser D, Schwind S.

Ann Hematol. 2018 May 22. doi: 10.1007/s00277-018-3373-y. [Epub ahead of print]

PMID:
29785446
3.

Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.

Schmalbrock LK, Bonifacio L, Bill M, Jentzsch M, Schubert K, Grimm J, Cross M, Lange T, Vucinic V, Pönisch W, Behre G, Franke GN, Niederwieser D, Schwind S.

Bone Marrow Transplant. 2018 May;53(5):640-643. doi: 10.1038/s41409-017-0060-x. Epub 2018 Jan 15. No abstract available.

PMID:
29335621
4.

High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients.

Jentzsch M, Bill M, Grimm J, Schulz J, Goldmann K, Beinicke S, Häntschel J, Pönisch W, Franke GN, Vucinic V, Behre G, Lange T, Niederwieser D, Schwind S.

Oncotarget. 2017 Sep 27;8(50):87944-87954. doi: 10.18632/oncotarget.21322. eCollection 2017 Oct 20.

5.

Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients.

Tsamadou C, Fürst D, Vucinic V, Bunjes D, Neuchel C, Mytilineos D, Gramatzki M, Arnold R, Wagner EM, Einsele H, Müller C, Schrezenmeier H, Mytilineos J.

Haematologica. 2017 Nov;102(11):1947-1955. doi: 10.3324/haematol.2017.169805. Epub 2017 Sep 7.

6.

Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality.

Dias A, Al-Kali A, Van Dyke D, Niederwieser D, Vucinic V, Lemke J, Muller C, Schwind S, Teichmann AC, Bakken R, Burns LJ, Litzow M.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1582-1587. doi: 10.1016/j.bbmt.2017.05.019. Epub 2017 May 23.

PMID:
28549770
7.

Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).

Tessenow H, Holzvogt M, Holzvogt B, Andrea M, Heyn S, Schliwa T, Schwarz M, Zehrfeld T, Becker C, Pfrepper C, Franke GN, Krahl R, Jentzsch M, Leiblein S, Schwind S, Bill M, Vucinic V, Lange T, Niederwieser D, Pönisch W.

J Cancer Res Clin Oncol. 2017 Oct;143(10):2049-2058. doi: 10.1007/s00432-017-2439-x. Epub 2017 May 22.

PMID:
28534173
8.

An unusual hypoechoic solid mass in the pancreatic head.

Blank V, Schierle K, Hacker U, Herta T, Vucinic V, Hoffmeister A, Mössner J, Jansen-Winkeln B, Keim V, Karlas T.

Z Gastroenterol. 2017 Apr;55(4):375-378. doi: 10.1055/s-0043-100023. Epub 2017 Apr 20.

PMID:
28427108
9.

Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning.

Bill M, Jentzsch M, Grimm J, Schubert K, Lange T, Cross M, Behre G, Vucinic V, Pönisch W, Franke GN, Niederwieser D, Schwind S.

Bone Marrow Transplant. 2017 Jun;52(6):932-935. doi: 10.1038/bmt.2017.42. Epub 2017 Apr 3. No abstract available.

PMID:
28368377
10.

A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens.

Backert L, Kowalewski DJ, Walz S, Schuster H, Berlin C, Neidert MC, Schemionek M, Brümmendorf TH, Vucinic V, Niederwieser D, Kanz L, Salih HR, Kohlbacher O, Weisel K, Rammensee HG, Stevanovic S, Walz JS.

Oncotarget. 2017 Jul 4;8(27):43915-43924. doi: 10.18632/oncotarget.14918.

11.

Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation.

Jentzsch M, Bill M, Nicolet D, Leiblein S, Schubert K, Pless M, Bergmann U, Wildenberger K, Schuhmann L, Cross M, Pönisch W, Franke GN, Vucinic V, Lange T, Behre G, Mrózek K, Bloomfield CD, Niederwieser D, Schwind S.

Am J Hematol. 2017 Apr;92(4):388-396. doi: 10.1002/ajh.24663. Epub 2017 Feb 21.

12.

Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.

Niederwieser C, Starke S, Fischer L, Krahl R, Beck J, Gruhn B, Ebell W, Körholz D, Wößmann W, Bader P, Lang P, Al-Ali HK, Cross M, Eisfeld AK, Heyn S, Vucinic V, Franke GN, Lange T, Pönisch W, Behre G, Christiansen H.

Ann Hematol. 2016 Feb;95(3):473-81. doi: 10.1007/s00277-015-2569-7. Epub 2015 Dec 23.

PMID:
26696465
13.

Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.

Poenisch W, Plötze M, Holzvogt B, Andrea M, Schliwa T, Zehrfeld T, Hammerschmidt D, Schwarz M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Gutsche K, Reifenrath K, Schwarzbach H, Heyn S, Franke GN, Jentzsch M, Leiblein S, Schwind S, Lange T, Vucinic V, AlAli HK, Niederwieser D.

J Cancer Res Clin Oncol. 2015 Nov;141(11):2013-22. doi: 10.1007/s00432-015-1984-4. Epub 2015 May 15.

PMID:
25976868
14.

Severe cutaneous necroses and hemorrhagic diathesis in a 73-year-old man.

Beyer S, Pfrepper C, Kronberg J, Vucinic V, Ziemer M, Simon JC, Niederwieser D, Treudler R.

J Dtsch Dermatol Ges. 2015 Mar;13(3):252-5. doi: 10.1111/ddg.12507. Epub 2015 Feb 23. English, German. No abstract available.

PMID:
25706675
15.

[Psychosocial aspects of strabismus].

Jablan B, Vucinić V, Eskirović B, Ljutica M.

Srp Arh Celok Lek. 2014 Jul-Aug;142(7-8):492-7. Review. Serbian.

16.

Treatment of neurosarcoidosis--innovations and challenges.

Stjepanović MI, Vucinić VM, Jovanović D, Mijajlović M, Trifunović VS, Stjepanović MM.

Med Pregl. 2014 May-Jun;67(5-6):161-6. Review.

PMID:
25033575
17.

Radiological presentation of neurosarcoidosis.

Stjepanović MI, Vucinić VM, Jovanović D, Mijajlović M, Trifunović VS, Ivanov JV.

Med Pregl. 2014 Jan-Feb;67(1-2):24-7. Review.

PMID:
24964564
18.

Diagnosis of neurosarcoidosis--necessity of biopsy.

Stjepanović MI, Vucinić VM, Jovanović D, Mijajlović M, Trifunović VS, Stjepanović MM.

Med Pregl. 2014 Mar-Apr;67(3-4):97-9.

PMID:
24961051
19.

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.

Pönisch W, Holzvogt B, Plötze M, Andrea M, Bourgeois M, Heyn S, Zehrfeld T, Hammerschmidt D, Schwarz M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Gutsche K, Reifenrath K, Winkelmann C, Krahl R, Remane Y, Hennig E, Schliwa T, Lindner T, Kaiser T, Vucinic V, Behre G, Niederwieser D.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1947-56. doi: 10.1007/s00432-014-1737-9. Epub 2014 Jun 19.

PMID:
24942335
20.

Sarcoidosis of the pleura--A case report.

Jovanović D, Vučinić V, Stević R, Milenkovic MR, Samardžić N, Velinović M, Stjepanović M.

Vojnosanit Pregl. 2014 May;71(5):506-9.

PMID:
26137718
21.

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.

Pönisch W, Moll B, Bourgeois M, Andrea M, Schliwa T, Heyn S, Schmalfeld M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Egert M, Stiegler R, Krahl R, Remane Y, Bachmann A, Lindner T, Weidhase L, Petros S, Fricke S, Vucinic V, Al Ali H, Niederwieser D.

J Cancer Res Clin Oncol. 2013 Nov;139(11):1937-46. doi: 10.1007/s00432-013-1513-2. Epub 2013 Sep 18.

PMID:
24046251
22.

High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

Fürst D, Müller C, Vucinic V, Bunjes D, Herr W, Gramatzki M, Schwerdtfeger R, Arnold R, Einsele H, Wulf G, Pfreundschuh M, Glass B, Schrezenmeier H, Schwarz K, Mytilineos J.

Blood. 2013 Oct 31;122(18):3220-9. doi: 10.1182/blood-2013-02-482547. Epub 2013 Sep 17. Erratum in: Blood. 2014 Mar 13;123(11):1768.

23.

Otitis media and facial paralysis as presenting symptoms of a primary middle ear sarcoidosis.

Arsovic N, Babic B, Dimitrijevic M, Bukurov B, Vucinic V.

Otol Neurotol. 2013 Oct;34(8):e121-2. doi: 10.1097/MAO.0b013e3182a09b21. No abstract available.

PMID:
24026033
24.

Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia.

Hebenstreit K, Iacobelli S, Leiblein S, Eisfeld AK, Pfrepper C, Heyn S, Vucinic V, Franke GN, Krahl R, Fricke S, Becker C, Pönisch W, Behre G, Niederwieser D, Lange T.

Leuk Lymphoma. 2014 Jun;55(6):1274-80. doi: 10.3109/10428194.2013.836598. Epub 2013 Oct 3.

PMID:
23964650
25.

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

Kornblit B, Maloney DG, Storb R, Storek J, Hari P, Vucinic V, Maziarz RT, Chauncey TR, Pulsipher MA, Bruno B, Petersen FB, Bethge WA, Hübel K, Bouvier ME, Fukuda T, Storer BE, Sandmaier BM.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1340-7. doi: 10.1016/j.bbmt.2013.06.002. Epub 2013 Jun 11.

26.

Endpoints for clinical trials of sarcoidosis.

Baughman RP, Drent M, Culver DA, Grutters JC, Handa T, Humbert M, Judson MA, Lower EE, Mana J, Pereira CA, Prasse A, Sulica R, Valyere D, Vucinic V, Wells AU.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):90-8. Review.

PMID:
23461070
27.

Mystery called sarcoidosis: forty-four years follow-up of chronic systemic disease.

Skodrić-Trifunović V, Vucinić V, Simić-Ogrizović S, Stević R, Stjepanović M, Ilić K, Savić Z.

Srp Arh Celok Lek. 2012 Nov-Dec;140(11-12):768-71.

28.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Pfeifer H, Wassmann B, Bethge W, Dengler J, Bornhäuser M, Stadler M, Beelen D, Vucinic V, Burmeister T, Stelljes M, Faul C, Dreger P, Kiani A, Schäfer-Eckart K, Schwerdtfeger R, Lange E, Kubuschok B, Horst HA, Gramatzki M, Brück P, Serve H, Hoelzer D, Gökbuget N, Ottmann OG; GMALL Study Group.

Leukemia. 2013 Jun;27(6):1254-62. doi: 10.1038/leu.2012.352. Epub 2012 Dec 5.

PMID:
23212150
29.

Fatigue in sarcoidosis: detection and treatment.

Vucinić V, Stojković M, Milenković B, Videnović-Ivanov J, Skodrić-Trifunović V, Zugić V, Gvozdenović B, Milovanović A, Filipović S.

Srp Arh Celok Lek. 2012 Jan-Feb;140(1-2):104-9. Review.

30.

Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia.

Tschiedel S, Bach E, Jilo A, Wang SY, Lange T, Al-Ali HK, Vucinic V, Niederwieser D, Cross M.

Leuk Lymphoma. 2012 Aug;53(8):1569-76. doi: 10.3109/10428194.2012.656631. Epub 2012 Mar 1.

PMID:
22251158
31.

How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review.

Vucinic V, Skodric-Trifunovic V, Ignjatović S.

Curr Opin Pulm Med. 2011 Sep;17(5):297-302. doi: 10.1097/MCP.0b013e328348b3cb. Review.

PMID:
21832916
32.

The influence of manifest strabismus and stereoscopic vision on non-verbal abilities of visually impaired children.

Gligorović M, Vučinić V, Eškirović B, Jablan B.

Res Dev Disabil. 2011 Sep-Oct;32(5):1852-9. doi: 10.1016/j.ridd.2011.03.018. Epub 2011 May 4.

PMID:
21536409
33.

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.

Bethge WA, Lange T, Meisner C, von Harsdorf S, Bornhaeuser M, Federmann B, Stadler M, Uharek L, Stelljes M, Knop S, Wulf G, Trenschel R, Vucinic V, Dittmann H, Faul C, Vogel W, Kanz L, Bunjes D.

Blood. 2010 Sep 9;116(10):1795-802. doi: 10.1182/blood-2010-02-270538. Epub 2010 Jun 7.

34.

[Association between tobacco smoking and pulmonary tuberculosis].

Trifunović VS, Gvozdenović BS, Jovanovic D, Vucinić V, Djurić D, Zunić M.

Vojnosanit Pregl. 2009 Oct;66(10):797-801. Serbian.

PMID:
19938757
35.

Eosinophil cell: pray tell us what you do!

Afshar K, Vucinic V, Sharma OP.

Curr Opin Pulm Med. 2007 Sep;13(5):414-21. Review.

PMID:
17940487
36.
37.

Sarcoidosis of the thyroid and kidneys and calcium metabolism.

Sharma OP, Vucinić V.

Semin Respir Crit Care Med. 2002 Dec;23(6):579-88.

PMID:
16088653
38.

[Liver and splenic sarcoidosis: diagnostic procedures].

Skodrić-Trifunović V, Vucinić V, Colović R, Videnović J, Zugić V, Stojsić J.

Med Pregl. 2004 Sep-Oct;57(9-10):462-6. Serbian.

PMID:
15675620
39.

Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burden.

Linck D, Basara N, Tran V, Vucinic V, Hermann S, Hoelzer D, Fauser AA.

Bone Marrow Transplant. 2003 May;31(10):935-7.

PMID:
12748673
40.

What is the future of methotrexate in sarcoidosis? A study and review.

Vucinic VM.

Curr Opin Pulm Med. 2002 Sep;8(5):470-6. Review.

PMID:
12172455
41.

Granulomatous lung diseases in the tropics.

Sharma OP, Vucinic V.

Clin Chest Med. 2002 Jun;23(2):329-39. Review.

PMID:
12092028
42.

Splenectomy in sarcoidosis: indications, complications, and long-term follow-up.

Sharma OP, Vucinic V, James DG.

Sarcoidosis Vasc Diffuse Lung Dis. 2002 Mar;19(1):66-70.

PMID:
12002389
43.

Enteric protein losing in sarcoidosis revisited.

Djordjević D, Popović OS, Necić D, Djurić O, Vucinić V.

Gastroenterology. 1992 Jul;103(1):355-6. No abstract available.

PMID:
1612352
44.
45.

[Multiple primary malignant tumors].

Radosavljević G, Vucinić V, Raković J, Sudzić E, Rajner L, Svabić-Dergenc Z, Jovanović D, Solujić M.

Plucne Bolesti. 1985 Jan-Jun;37(1-2):64-8. Croatian. No abstract available.

PMID:
4070483

Supplemental Content

Loading ...
Support Center